Best Immunotherapy with Keytruda (Pembolizumab) doctors: TOP 55 doctors

• Specializes in immunotherapy with Keytruda for various cancers.
• Trained in immunooncology in the UK and Israel.
• Certified by the European Society of Medical Oncology (ESMO).
• Member of ESMO and European School of Oncology.
• Fluent in English, Turkish, and Russian (B1 level).

• Specializes in immunotherapy with Keytruda for various cancers.
• Trained in Turkey and the USA at MD Anderson Cancer Center.
• Certified in Medical Oncology, member of several oncology societies.
• Fluent in English and Turkish, enhancing communication with diverse patients.
• Uses patient-specific treatment planning for Keytruda administration.

• Specializes in immunotherapy with Keytruda for hematologic cancers.
• Trained in Japan and Turkey, enhancing his expertise in advanced therapies.
• Member of several international hematology and oncology associations.
• Published extensively on hematologic malignancies and treatment methods.
• Holds a PhD in Hematology from Japan Mie Medical Faculty.

Prof. Baytan is a doctor who graduated from Ankara University Medical Faculty in 1992 and became a Specialist in Medicine at Uludağ University Faculty of Medicine, Department of Child Diseases. He is experienced in the diagnosis and treatment of childhood cancers, leukemia, anemia, and other diseases. He has 15 articles published in international refereed journals, 9 full texts presented and published in international scientific meetings, 3 books/book chapters written, and 8 articles published in local refereed journals.

• Dr. Ofer Merimsky specializes in immunotherapy with keytruda (pembolizumab) for lung cancer patients.
• Trained in radiotherapy and brachytherapy at New York Hospital, USA.
• Member of the American Scientific Cancer Society and European Society of Oncology.
• Certified by the Israeli Society for Oncology and Radiotherapy.
• Active member of the American Society of Clinical Oncology (ASCO), USA.

• Dr. Pelles Sharon specializes in immunotherapy with keytruda (pembrolizumab) for cancer treatment.
• Utilizes precise biomarker testing to tailor keytruda (pembrolizumab) therapy for individual patients.
• Received advanced training in immunotherapy in the USA and Germany.
• Certified by the American Board of Oncology and a member of the European Society for Medical Oncology.
• Speaks English, German, and Hebrew fluently.

• Dr. Ralf Buhl specializes in immunotherapy with keytruda (pembrolizumab) for cancer treatment.
• He has international practice experience in China and the United States.
• Dr. Buhl is a recognized expert in non-invasive cancer treatments.
• He is a member of several prestigious medical organizations.
• Dr. Buhl is a Doctor of Medical Sciences with numerous scientific publications.

• Dr. David Sarid specializes in immunotherapy with pembrolizumab for different types of cancer.
• He trained in Israel, the UK, and Georgia, which broadened his medical perspective.
• He is a member of the European Society for Medical Oncology and the American Society of Clinical Oncology.
• He has authored over 30 articles on cancer treatment, contributing to medical research.
• He is a lecturer at Tel Aviv University, where he shares his knowledge of cancer therapies.

• Specializes in immunotherapy with pembrolizumab for cancer treatment.
• Completed a fellowship in Hematology and Oncology in the USA.
• Board-certified in Internal Medicine, Hematology, and Medical Oncology.
• Published more than 30 scientific articles in medical journals.
• Director of the Bone Marrow Transplantation Department.

• Specializes in immunotherapy with keytruda (pembolizumab) for pediatric patients.
• Practiced at the City of Hope Hospital in Los Angeles and in Israel.
• Member of the American Association for Hematology and the Israeli Society for Pediatric Hematooncology.
• Published numerous papers and reports on pediatric hemato-oncology.
• Head of the Pediatric Oncohematology and Oncology Department at Dana Dwek Children’s Hospital.

Dr. Girish V. Badarkhe is an experienced hematology-oncologist at HCG Manavata Cancer Centre, Nashik, with MBBS, MD, and DM degrees. He has 13+ years of expertise in leukemia, multiple myeloma, and bone marrow transplant, and has received awards for his professional and hard work.

• Specializes in immunotherapy with Keytruda for liver cancer treatments.
• Trained in Germany, collaborates internationally on oncology protocols.
• Certified in Surgical Oncology and General Surgery.
• Member of the International Hepato-Pancreato-Biliary Association.
• Utilizes multidisciplinary approaches with oncologists and radiologists.

Prof. Songul Serefhanoglu is a Hematologist at ISU Medical Park since 2019, and has been the Director and President of Adult Hematology Department of Sisli Memorial Hospital, Istanbul since 2019. He completed his Medical Education from Firat University, Elazig/Turkey (1994-2000), Internal Medicine from Inonu University, Malatya/Turkey (2001-2005), and Hematology from Hacettepe University, Ankara/Turkey (2006-2009). He has been involved in peripheral hematopoietic stem cell transplantation, with an average of 100-120/year.

• Dr. Manuela Seifert specializes in immunotherapy with pembrolizumab for breast cancer treatment.
• Trained in Germany, Dr. Seifert brings international expertise to her practice.
• Recognized for her excellence in breast cancer treatment and innovative approaches.
• Certified in gynecology and obstetrics, and a member of leading medical organizations.
• Dr. Seifert's empathetic care ensures personalized treatment plans for each patient.

Dr. Raj is a highly experienced Surgical Oncologist with 19 years of experience and over 50,000 cancer surgeries performed. He is involved in numerous clinical trials and has many international and national publications to his credit. He specializes in Breast and Thoracic Surgical Oncology and serves as a professor for DNB Superspecialty Surgical Oncology and Breast Surgery at the Maharashtra University of Health Sciences. His belief is in "adding life to years" and improving the quality of life, not just adding years to life.

• Specializes in immunotherapy with Keytruda for hematological malignancies.
• Trained in Immunology in Germany, extensive international lectures.
• Member of the German Society of Hematology and Medical Oncology.
• Provides remote consultations for immunotherapy with Keytruda.
• Chief Physician at the Oncology and Hematology Center, Bremen.

• Specializes in immunotherapy with Keytruda for non-Hodgkin lymphoma.
• Trained in Germany, the USA, and the UK in advanced hematological therapies.
• Certified by the American Board of Hematology.
• Member of the European Hematology Association.
• Fluent in English, German, and basic French.

Dr. Axel Stang is a professor, Head Physician of Asklepios Barmbek Clinic, with a specialization in internal medicine, oncology, and hematology. He conducts antibody and molecular therapies to reduce tumor size, and is a member of multiple organizations and societies. Dr. Stang has published articles on the effectiveness of radiofrequency ablation in treating of metastatic colon cancer, and was a member of a research group that studied the effects of liver embolization. Patients can submit a request on the Bookimed website to get a consultation with the professor.

Dr. Auala Hubert is a board-certified Medical Oncologist & Radiotherapist with 33 years of experience, speaking both English and Hebrew. She is a member of several medical and social service committees and holds qualifications in Oncology and Radiotherapy.